- Home
- App Analytics
- Voice Crisis Alert V2
- Voice Crisis Alert V2 Vs. SCD Warrior
Voice Crisis Alert V2 vs SCD Warrior Uso e estatísticas
App for sickle cell patients currently enrolled in the Voice Crisis Alert Study.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
If you are a person with Sickle Cell Disease, SCD Warrior can help you to track your treatment and share your progress with your healthcare providers.
Download the application to:
* Keep your doctors, nurses, social and community health workers one tap away.
* Track your meds, symptoms and lifestyle. Anytime. Anywhere.
* Personalize your treatment and get timely reminders.
* Access and share your records on the go! It’s both easy and secure.
* Learn more about living with Sickle Cell Disease (SCD).
* Manage pain crisis situations much more effectively.
---
NOTE FOR HEALTHCARE PROFESSIONALS: This mobile app is designed for patient use only. Please visit https://scdwarrior.com to create a professional account. If you have questions, you can contact us at feedback@scdwarrior.com
NOTE FOR PATIENTS AND FAMILIES: The purpose of this mobile app is to provide the Sickle Cell community with a digital tool to better navigate their patient journey. However, the app is not intended to provide professional medical advice or replace it. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding your condition.
- Apple App Store
- Gratuitos
- Saúde e fitness
Ranking da Loja
- -
Voice Crisis Alert V2 versus SCD Warrior comparação de classificação
Compare a tendência de classificação de Voice Crisis Alert V2 nos últimos 28 dias versus SCD Warrior
Classificação
Nenhum dado disponível
Comparação da classificação de Voice Crisis Alert V2 vs. SCD Warrior por país
Compare a tendência de classificação de Voice Crisis Alert V2 nos últimos 28 dias versus SCD Warrior
Nenhum dado para exibir
Faça comparações com qualquer site com o nosso teste grátis
Voice Crisis Alert V2 VS.
SCD Warrior
19ezembro d, 2024